Johnson & Johnson (JNJ)

Common Stock
Sell: $154.10|Buy: $154.90|Change: 1.85 (-1.18%)

Company profile

Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: pharmaceutical and medical devices. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. Geographically, just over half of total revenue is generated in the United States.

Address

One Johnson and Johnson Plaza
New Brunswick
NJ
USA
08933


Telephone

+1 781 5752718


Sector 

Healthcare


Previous key dates

NameKey Date
Johnson & Johnson to Participate in the 2025 RBC Capital Markets Global Healthcare Conference2025-05-27T13:35:00
BofA Securities 2025 Healthcare Conference2025-05-13T13:40:00
Johnson & Johnson Annual General Meeting for 20252025-04-25T10:00:00
Johnson & Johnson First Quarter Earnings Conference Call for 20252025-04-15T08:30:00
Johnson & Johnson First Quarter Earnings Results for 20252025-04-15T06:45:00
45th Annual TD Cowen Healthcare Conference2025-03-04T11:10:00
Johnson & Johnson Annual Report for 20242025-02-13T00:00:00
Johnson & Johnson Fourth Quarter Earnings Conference Call for 20242025-01-22T08:00:00
Johnson & Johnson Fourth Quarter Earnings Result for 20242025-01-22T00:00:00
43rd Annual J.P. Morgan Healthcare Conference2025-01-13T12:00:00
Stifel 2024 Healthcare Conference2024-11-18T10:55:00
Johnson & Johnson to Participate in the Guggenheim Global Healthcare Conference2024-11-12T10:30:00
Johnson & Johnson Third Quarter Earnings Conference Call for 20242024-10-15T08:30:00
Johnson & Johnson Third Quarter Earnings Result for 20242024-10-15T00:00:00
Johnson & Johnson to Participate in the 2024 Wells Fargo Healthcare Conference2024-09-05T11:00:00
22nd Annual Global Healthcare Conference2024-09-04T10:45:00
Johnson & Johnson Second Quarter Earnings Conference Call for 20242024-07-17T08:30:00
Johnson & Johnson Second Quarter Earnings Results for 20242024-07-17T06:45:00
Johnson & Johnson to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference2024-06-12T14:00:00
Johnson & Johnson to Participate in the 2024 RBC Capital Markets Global Healthcare Conference2024-05-15T11:00:00
Johnson & Johnson BofA Securities Health Care Conference 20242024-05-14T16:40:00
Johnson & Johnson Investor Conference Call2024-05-01T08:00:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2025 AJ Bell. All rights reserved.